GMJ Briefs
Big Tech Controls 62% of Health AI Market as Public Initiatives Lag Behind
Big tech companies control 62 percent of the 45 billion dollar health AI market, while public initiatives represent only 3…
Three Critical Insights into UK Pharmaceutical Import Licensing and Patient Medicine Access
UK parallel import licensing reveals critical insights on medicine access, supply chain adaptation, and maintained safety standards post-Brexit.
UK Maternal Healthcare Crisis: Inadequate Breastfeeding Support Drives Mothers Away from Future Pregnancies
UK survey reveals traumatic breastfeeding experiences are influencing maternal family planning decisions due to inadequate hospital support systems.
Data Point: Finerenone Cuts Kidney Disease Progression by 23% in Non-Diabetic Populations
A 23% relative risk reduction in kidney disease progression marks finerenone as a meaningful therapeutic option for non-diabetic CKD patients…
What UK Patients Need to Know About 2026’s Landmark Medicine Approvals
UK patients now have access to 47 newly approved medicines in 2026, with neurological treatments and oncology therapies offering expanded…
One Cup of Spinach Daily Associated with Lower Dementia Risk in Large-Scale Study
Long-term tracking of 54,000+ adults shows one cup daily of spinach-equivalent vegetable nitrates reduces dementia risk while water and meat…
What This Anxiety Breakthrough Means for Future Treatment Development
Three key findings from anxiety circuit research point toward more precise, targeted treatments with fewer side effects.
Experimental Compound Slows Nerve Cell Loss in Alzheimer’s Preclinical Studies
An experimental compound reduced nerve cell loss in Alzheimer's mouse models by targeting a newly identified cellular mechanism distinct from…